Target intelligence / Profile preview

Exosome complex component CSL4 (EXOSC1)

Target
EXOSC1
Molecular classification
Other (RNA exosome complex subunit), RNA-binding protein
01

Overview

Exosome complex component CSL4 (EXOSC1) is a non-catalytic, peripheral subunit of the multi-protein RNA exosome complex, which is essential for 3'→5' RNA degradation and processing in both the nucleus and the cytoplasm. The exosome complex is responsible for maturation of stable RNA species (rRNA, snRNA, snoRNA), elimination of aberrant or non-coding RNAs, general turnover of mRNA (including those with AU-rich elements), and RNA surveillance pathways, thus preventing accumulation of defective RNAs. As part of the S1/KH cap of the exosome core, EXOSC1 is essential for binding nascent RNA and stabilizing the exosome structure. New evidence suggests that in certain contexts, such as kidney cancer, EXOSC1 can act independently of the full exosome complex, cleaving single-stranded DNA and promoting DNA damage, thus creating a unique role in DNA mutagenesis and therapeutic sensitization to PARP inhibitors. Loss of EXOSC1 is developmentally lethal in mice, underlining its critical function in cellular RNA metabolism. There are currently no approved therapeutics directly targeting EXOSC1, but its potential as a biomarker or sensitizer to DNA repair-targeted therapies is under investigation.

Other names
Exosome component 1CSL4CGI-108hCsl4pCsl4pSki4pSKI4p13exosome complex component CSL43'-5' exoribonuclease CSL4 homologexosomal core protein CSL4homolog of yeast exosomal core protein CSL4PCH1F
02

Mechanism of action

Not a classical drug target; however, loss or inhibition of EXOSC1 may increase DNA damage and sensitize cells to DNA repair inhibitors such as PARP inhibitors

03

Biological functions

RNA degradationRNA processingMaturation of stable RNAs (rRNA, snRNA, snoRNA)Elimination of aberrant and non-coding RNAsRegulation of mRNA turnoverRNA surveillancePossible involvement in DNA damage and mutagenesis in cancer
04

Disease associations

Pontocerebellar hypoplasia, type 1FPontocerebellar hypoplasia, type 1ECancer (notably kidney renal clear cell carcinoma)
05

Safety considerations

Essential for early embryonic developmentLoss of function is lethal at early mammalian developmental stagesInvolvement in RNA processing—broad inhibition could affect global gene expression and cell viability
06

Interacting drugs

None directly identified; may sensitize cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors
07

Biomarkers

High EXOSC1 expression may be a negative prognostic biomarker in kidney renal clear cell carcinoma

Beyond the preview

Go deeper on Exosome complex component CSL4 (EXOSC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exosome complex component CSL4 (EXOSC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call